Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Income (Loss)

v3.19.1
Consolidated Statements of Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenue
Expenses:    
Research and development 18,733 6,274
General and administrative 10,374 5,552
Operating Expenses 29,107 11,826
Other income (expense):    
Interest income 283 68
Foreign exchange gains( losses) (44) 115
Total other income 239 183
Income (loss) before income taxes (28,868) (11,643)
Other comprehensive loss:    
Unrealized loss on securities available-for-sale 18
Total comprehensive loss $ (28,868) $ (11,661)
Basic and diluted loss per common share (in dollars per share) $ (0.86) $ (0.52)
Weighted average number of common shares outstanding used in the calculation of (in thousands) Basic and diluted loss per common share (in shares) 33,391 22,313